Analysis of Turnaround Time by Subdividing Three Phases for Outpatient Chemistry Specimens
|
|
- Jade Lucas
- 6 years ago
- Views:
Transcription
1 144 Available online at Annals of Clinical & Laboratory Science, vol. 39, no. 2, 2009 Analysis of Turnaround Time by Subdividing Three Phases for Outpatient Chemistry Specimens Hee-Jung Chung, 1 Woochang Lee, 1 Sail Chun, 1 Hae-Il Park, 2 and Won-Ki Min 1 1 Department of Laboratory Medicine, University of Ulsan College of Medicine, and Asan Medical Center, Seoul; 2 Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea Abstract. The Department of Laboratory Medicine at Asan Medical Center provides a special one-stop service to allow both doctors and outpatients to receive routine outpatient test results in a timely manner within 1 hr. We developed a new Laboratory Information System (LIS)-based monitoring system that records the laboratory turnaround time (TAT) in 3 phases and analyzes the time to complete each phase with relevant specimens. TAT is subdivided into preanalytical, analytical, and postanalytical phases based on the 4 time points when data are entered automatically into the LIS. The average TAT for 13,594 outpatient routine chemistry specimens with the one-stop service was 43.6±7.7 min. Completion times of the preanalytical, analytical, and postanalytical phases were 29.7±6.9, 13.9±4.1, and 0.02±0.13 min, respectively; 98.0% of the specimens were reported within 60 min. The remaining 2.0% were reported after 60 min with an average TAT of 68.7±11.3 min. Preanalytical phase delays were primarily responsible for the specimens reported between 60 and 90 min, and analytical phase delays were largely responsible for the few specimens (0.2%) reported after 90 min. For specimens reported between 60 and 90 min, the preanalytical phase was found to need improvement in order to shorten TAT; the main target for improvement was identified as the waiting time for phlebotomy step. Keywords: automation, clinical laboratory service, laboratory test turnaround time Introduction The laboratory turnaround time can be defined differently according to the test type (stat vs routine), analyte, and institution. It is commonly defined as the time from when a test is ordered until the result is reported [1]. The Department of Laboratory Medicine at Asan Medical Center defines the laboratory turnaround time (TAT) for outpatients as the time taken from printing a barcode to reporting the test result. Address correspondence to Won-Ki Min, M.D., Ph.D., Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Pungnap-2dong, Songpa-gu, Seoul , Republic of Korea; tel ; fax: ; wkmin@amc.seoul.kr. Asan Medical Center is a 2,200-bed tertiary care teaching hospital that receives 8,000 outpatients every day. The Department of Laboratory Medicine performed 30 million tests in The department offers an expedited one-stop service to outpatients for routine chemistry, hematology, diabetes, coagulation, urinalysis, and stat tests. The one-stop service aims to allow doctors and outpatients to receive test results in a timely manner within 1 hr. We reported previously that the percentages of outpatient specimen results reported within 60 min for routine hematology, chemistry, urinalyses, coagulation, and diabetes tests were 80.1, 91.9, 99.5, 92.6, and 97.6%, respectively [2]. Traditionally, laboratory TAT is determined by the timely progress of 3 phases of testing: preanalytical, analytical, and postanalytical [3,4]. Smellie et al [5] assessed the TAT based on the /09/ $ by the Association of Clinical Scientists, Inc.
2 Analysis of three phases of laboratory turnaround time 145 timeliness of these individual phases by manual records, but there have been no previous reports of the use of a laboratory information system (LIS) to record and analyze TAT. Therefore, we designed a new LIS that records TAT data automatically and analyzes the time taken for the 3 phases that comprise the total laboratory TAT for each test. Materials and Methods This study utilized 13,594 outpatient specimens that were received from 8:00 a.m. until 5:00 p.m. at Asan Medical Center for routine one stop chemistry tests between 30 July 2007 and 26 August Various automated instruments were used for specimen testing: three TBA 200FR (Toshiba Medical System Co., Tokyo Japan), two TBA 200FRNeo (Toshiba), three COBAS Integra 800 (Roche Diagnostics, Basel, Switzerland), and four Synchron LX 20 (Beckman Co., Fullerton, CA, USA). A total of 207,143 tests were performed; the 30 routine chemistry analytes were plasma total calcium, glucose, creatinine, uric acid, cholesterol, protein, albumin, AST, ALT, ALP, total bilirubin, direct bilirubin, phosphorous, urea, gamma-glutamyl transferase, sodium, potassium, chloride, total CO 2, amylase, lactate dehydrogenase, triglyceride, HLD-cholesterol, LDL-cholesterol, C-reactive protein, magnesium, lipase, CK, iron, and TIBC. A program was developed to record and manage the time points entered into the LIS, the time taken to fulfill each phase, the testing instruments, the operators, retesting, and verification, such as delta value, panic value, and critical value checking. During laboratory test processing at Asan Medical Center, 4 time points were automatically recorded in LIS: ie, barcode printing when the barcode was printed by an autolabeler and the specimen was accessed simultaneously; scanning when the barcode was scanned in the autoanalyzer; result to LIS when the result was transmitted from the instrument to the LIS after the analysis; and result to HIS when the verified result was transmitted from the LIS to the hospital information system (HIS). In this study, the TAT was classified into 3 phases on the basis of these 4 time points, ie, preanalytical phase (barcode printing scanning), analytical phase (scanning result to LIS), and postanalytical phase (result to LIS report to HIS) (Fig. 1). The preanalytical phase consists of the following steps: barcode printing with simultaneous specimen accession; the wait for phlebotomy; phlebotomy; transport of the specimen from the blood-collection site to the laboratory via a conveyer belt; manual centrifugation; manual specimen loading on an autoanalyzer; and barcode scanning in the autoanalyzer. The analytical phase occurs in the autoanalyzer and consists of the following steps: barcode scanning; order retrieval from the LIS; analysis; and the result is sent to the LIS. The postanalytical phase consists of the following steps: the result is received by the LIS; verification (automatic or manual); and the report is sent to the HIS. The mean TAT, standard deviation (SD), proportion of acceptable tests (% of TAT within 60 min), 90th percentile, 95th percentile, and 99th percentile of TAT were evaluated for the 13,594 specimens. The specimens were divided into 3 groups; TAT within 60 min, TAT between 60 and 90 min, and TAT after 90 min. The average time taken to fulfill each phase was measured, and the contribution of each phase to Table 1. Mean and proportion of overall TAT in each group: the TAT within 60 min; the TAT between 60 and 90 min; and the TAT greater than 90 min. Group Specimens Specimens reported Overall TAT no. (%) after 60 min (%) (min, mean ± SD)* Specimens reported within 60 min 13,328 (98.0%) 43.1±6.7 Specimens reported after 60 min 266 (2.0%) 100.0% 68.7±11.3 Specimens reported between 60 and 90 min 238 (1.8%) 89.5% 65.3±5.8 [+22.2] Specimens reported after 90 min 28 (0.2%) 10.5% 96.9±4.9 [+53.8] All one-stop service specimens 13,594 (100%) 2.0% 43.6±7.7 * The mean TAT duration that exceeded the TAT of specimens reported within 60 min is enclosed in brackets. Table 2. Mean TAT of each phase, according to their groups. Group Preanalytical Analytical phase Postanalytical phase of TAT (min)* of TAT (min)* phase of TAT (min)* Specimens reported within 60 min Specimens reported between 60 and 90 min 42.9 [+13.5] 22.4 [+8.7] 0.02 [+0.00] Specimens reported after 90 min 35.5 [+6.1] 61.4 [+47.7] 0.02 [+0.00] * The mean TAT duration that exceeded the TAT of specimens reported within 60 min is enclosed in brackets.
3 146 Annals of Clinical & Laboratory Science, vol. 39, no. 2, 2009 Fig. 1. Laboratory flow of the one-stop service specimens at Asan Medical Center. Fig. 2. Histograms showing the distribution of TAT: (A. upper left panel) overall TAT; (B. upper right panel) preanalytical TAT; (C. lower left panel) analytical TAT; (D. lower right panel) postanalytical TAT.
4 Analysis of three phases of laboratory turnaround time 147 Fig. 3. Percentage of each phase according to group: (A. left) specimens reported within 60 min; (B. center) specimens reported between 60 and 90 min; (C. right) specimens reported after 90 min. the overall TAT was calculated. When specimen results were reported after 60 min, each phase was investigated to determine the underlying reason for the lack of timeliness. Statistical software SPSS (version 13.5, SPSS Inc., Chicago, IL, USA) was used for data analysis. Results Overall TAT and TAT of the 3 phases. Fig. 2 shows the distribution of TAT of the 13,594 specimens. The average TAT was 43.6±7.7 min; 98.0% of specimens were reported within 60 min, and the time to 90th percentile of TAT was 51.8 min. The times taken to complete each of the 3 phases (preanalytical, analytical, and postanalytical) were 29.7±6.9, 13.9±4.1, and 0.02±0.13 min, respectively (Table 1). The preanalytical, analytical, and postanalytical phases accounted for 68.1%, 31.9%, and 0.05% of overall TAT, respectively. Specimens reported within 60 min. Specimen results that were reported within 60 min accounted for 98.0% (13,328/13,594) of the specimens tested, and the average TAT was 43.1±6.7 min. The times taken to complete the phases were as follows: preanalytical, 29.4±6.1 min; analytical, 13.7±3.0 min; and postanalytical, 0.02±0.13 min (Table 1). These phases accounted for 68.2% (preanalytical), 31.8% (analytical), and 0.05% (postanalytical) of the TAT, respectively (Fig. 3A). Specimens reported after 60 min. The results of analysis that were reported after 60 min accounted for 2.0% (266/13,594) of the tested specimens; the average TAT was 68.7±11.3 min. Test results reported between 60 and 90 min accounted for 89.5% (238/266) of the specimens reported after 60 min, and results from analyses reported after 90 min accounted for the remaining 10.5% (28/266). TATs of the specimens reported between 60 and 90 min and after 90 min were 65.3±5.8 and 96.9±4.9 min, respectively (Table 1, Fig. 3B and 3C). For specimen testing results reported between 60 and 90 min, the TAT of the preanalytical, analytical, and postanalytical phases was longer than those of the standard specimens by as much as 13.5, 8.7, and 0.0 min, respectively. The root cause of the prolonged preanalytical phase was the waiting time for phlebotomy (barcode printing/ phlebotomy) and the waiting time for analysis (specimen loading/barcode scanning) In the case of specimens reported after more than 90 min, the TAT of the three phases was longer than those of the standard specimens by as much as 6.1, 47.7, and 0.0 min, respectively (Table 2). The root cause of the prolonged analytical phase was repeated tests. Discussion During the present study period, a total of 85,221 specimens were referred to the Department of Laboratory Medicine. Inpatient specimens accounted for 47.9% (40,840) and outpatient and quality control specimens accounted for 47.9% (40,794) and 4.2% (3,587) of the total specimens, respectively. Specifically, 13,594 specimens were subjected to the one-stop service testing, and this accounted for 33.3% of outpatient specimens (13,594/40,794) received. Thus, the expedited onestop service was utilized by many outpatients.
5 148 Annals of Clinical & Laboratory Science, vol. 39, no. 2, 2009 In a 1998 CAP Q-Probes Study, 41.1% of laboratories defined emergency department (ED) TAT as the time taken from receipt of a specimen in the laboratory to reporting of the test result, 27.0% defined it as the time taken from the test order to reporting of the result, and 18.2% defined it as the time taken from collecting a specimen to reporting the result [6]. Nevertheless, 40.2% of clinicians answered that ED TAT starts from the time of the physician s test request [6]. Hence, laboratories and clinicians maintained wide differences of opinion concerning laboratory TAT. Furthermore, there have been no previous studies related to laboratory TAT from the standpoint of the patients. The maximal TAT should be calculated from the time at which a patient enters the blood collection site. Accordingly, in the Asan Medical Center, laboratory TAT starts from barcode printing to reflect the maximal TAT from the standpoint of the patients. This does not include the time interval for receiving patients, which takes approximately 2 min. Asan Medical Center gives priority to emergency specimens followed by the one-stop service specimens. A 2004 CAP Q-Probes study reported that the 90th percentile of order-to-report TAT for CK-MB was 66.5 min and that of troponin was 61.0 min for ED specimens [7]. In our analysis, the 90th percentile of overall TAT (barcode printing to report) for the one-stop service specimens was 51.8 min. Many researchers have reported various methods to shorten laboratory TAT [8-15]. Lewandrowski et al [13] reported that TAT can be shortened by running a satellite laboratory. Fernandes et al [10] reported that the time taken to convey specimens can be shortened by using a pneumatic tube system. Steindel et al [14] analyzed TAT outliers that caused delays. As reported previously, this laboratory has introduced various systems to shorten the TAT of outpatient testing [2] and has established the present system. First, this laboratory runs a separate satellite laboratory for outpatient testing. Second, a continuous conveyor belt has been set up between the blood collection site and the outpatient laboratory so that specimens can be relayed automatically to the outpatient laboratory after phlebotomy. Third, similar to the report of Steindel et al [14], a realtime TAT monitoring system was developed whereby TAT can be investigated based on TAT outliers, sample reference time, or test items. Fourth, aside from the methods reported by other researchers, this system was arranged so that specimens can be accepted simultaneously after the autolabeler prints a barcode, which saves labor and time. Fifth, a Priority System for Specimens was set up so that the one-stop service specimens can be selected from among outpatient specimens, and their results can be reported within 1 hr. Finally, for outpatient specimens, clotting time was saved by using plasma separating tubes. The subdivided TAT monitoring system developed here is based on the 4 time points recorded automatically in the LIS. We devised an additional output sheet on the LIS to show the TAT of each phase with integrated information, such as the ID of the tested autoanalyzer, whether it was retested or diluted, the method of dilution (manual or auto), and verification (delta, panic, and critical value checks). Consequently, the three phases (preanalytical, analytical, and postanalytical phases) that were applied to this TAT monitoring system are different from previous systems [16,17]. The analytical phase was fixed according to the test items of each instrument, because the variable waiting time for analysis (specimen loading barcode scanning) was excluded. The Toshiba autoanalyzers used in this hospital take 12.9 to 14.2 min to perform analyses, depending on the test items. The Synchron LX 20 autoanalyzers take 12.7 to 21.8 min, and the COBAS Integra 800 autoanalyzers take 13.5 to 20.2 min. In the preanalytical phase (Fig. 1), phlebotomy takes an average of 1 min, 30 sec, per patient, and tube preparation time can be reduced by using an autolabeler. The transport step takes 2 min, 20 sec, to 4 min, 20 sec, depending on where the blood specimen is placed on the conveyor belt. The centrifugation step is performed by 2 staff members using 5 Union 5KR centrifuges (Hanil Science Industrial Co., Seoul, Korea); it can be completed routinely within 14 min, including a waiting time of 4 min. The preanalytical phase was markedly affected by these 2 variable steps: waiting time for phlebotomy (barcode printing phlebotomy) and
6 Analysis of three phases of laboratory turnaround time 149 waiting time for analysis (specimen loading barcode scanning). In particular, the waiting time for phlebotomy took 7.3±4.3 min, and this step accounted for 24.8% of the preanalytical phase in our further investigation over a 2-wk period. The waiting time for phlebotomy could easily be shortened by increasing the numbers of phlebotomy desks and relevant staff. Hence, 2 more blood collection sites are scheduled to open in addition to the existing site to shorten patients waiting time for phlebotomy. The preanalytical TAT of specimens reported after 60 min took 12.8 min longer than that of specimens reported within 60 min. Hence, it appears that improvement of the preanalytical phase (especially waiting time for phlebotomy) would significantly decrease the TAT. The time spent waiting for analysis could not be measured using the current system. To reduce waiting time for analysis, this hospital laboratory uses multiple autoanalyzers and prioritizes specimens for the one-stop service. Manor [18] and Rollo et al [19] reported that non-analytical delays, such as transporting and reporting delays, are the main causes of lagging laboratory TAT. The 0.2% of specimens that were reported after 90 min comprised only 28 specimens. For one specimen from a child, the preanalytical phase took 72.4 min due to difficulty in blood collection. In another 20 specimens, retests had to be performed, which resulted in delays. In this group, the preanalytical and analytical phases accounted for 36.6 and 63.4% of overall TAT, respectively. In summary, we subdivided laboratory TAT into 3 phases, preanalytical, analytical, and postanalytical, which were applied to one-stop outpatient specimens. In the majority of specimens (98.0%) test results were reported within 60 min, and only 2.0% of specimens were delayed. For specimens reported between 60 and 90 min (89.5% of delayed specimens), the preanalytical phase was in need of improvement to shorten TAT, and the main target for improvement was the waiting time for phlebotomy step. References 1. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev 2007;28: Lee W, Min WK, Chun S, Jang S, Chi HS, Park CJ et al. Reorganization of automated outpatient laboratory to improve total turn around time. Korean J Lab Med 2004;24: Truchaud A, Le Neel T, Brochard H, Malvaux S, Moyon M, Cazaubiel M. New tools for laboratory design and management. Clin Chem 1997;43: Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem 1998;44: Smellie WS, Johnston J, Galloway PJ. Method for assessment of laboratory turnaround times: comparison before, during, and after analysis. J Clin Pathol 1994;47: Steindel SJ, Howanitz PJ. Physician satisfaction and emergency department laboratory test turnaround time. Arch Pathol Lab Med 2001;125: Novis DA, Jones BA, Dale JC, Walsh MK. Biochemical markers of myocardial injury test turnaround time: a College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-mb determinations in 159 institutions. Arch Pathol Lab Med 2004;128: Carraro P, Plebani M. Process control reduces the labor-atory turnaround time. Clin Chem Lab Med 2002;40: Chien TI, Lu JY, Kao JT, Cheng YC, Lee YF. Evaluation and improvement strategy of analytical turnaround time in the stat laboratory. J Formos Med Assoc 2007;106: Fernandes CM, Worster A, Eva K, Hill S, McCallum C. Pneumatic tube delivery system for blood samples reduces turnaround times without affecting sample quality. J Emerg Nurs 2006;32: Howanitz JH, Howanitz PJ. Laboratory results. Timeliness as a quality attribute and strategy. Am J Clin Pathol 2001;116: Huang YW, Chen WH, Wu HJ, Chien HY, Lin TY, Chiang HH et al. Learning curve of a new hospital laboratory. The monitoring of computer-generated turn-around time of laboratory tests in an emergency department. Clin Chem Lab Med 2003;41: Lewandrowski K. How the clinical laboratory and the emergency department can work together to move patients through quickly. Clin Leadersh Manag Rev 2004;18: Steindel SJ, Novis DA. Using outlier events to monitor test turnaround time. Arch Pathol Lab Med 1999;123: Westbrook JI, Georgiou A, Dimos A, Germanos T. Computerised pathology test order entry reduces laboratory turnaround times and influences tests ordered by hospital clinicians: a controlled before and after study. J Clin Pathol 2006;59: Steindel SJ, Jones BA. Routine outpatient laboratory test turnaround times and practice patterns: a College of American Pathologists Q-Probes study. Arch Pathol Lab Med 2002;126: Valenstein P, Walsh M. Five-year follow-up of routine outpatient test turnaround time: a College of American Pathologists Q-Probes study. Arch Pathol Lab Med 2003;127: Manor PG. Turnaround times in the laboratory: a review of the literature. Clin Lab Sci 1999;12: Rollo JL, Fauser BA. Computers in total quality management. Statistical process control to expedite stats. Arch Pathol Lab Med 1993;117:
Determination of Delay in :flirn Around Time (TAT) of Stat Tests and its Causes: an AKUH Experience
Determination of Delay in :flirn Around Time (TAT) of Stat Tests and its Causes: an AKUH Experience F. Bilwani,I. Siddiqui,S. Vaqar ( Section of Chemical Pathology, Department of Pathology, Aga Khan University
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-30 U/L 10-30 U/L 10-20 U/L Albumin 0-6 days 6 days - 37 months 37 months - 7 years 7-20 years 2.6-3.6 g/dl 3.4-4.2 g/dl
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-25 U/L 10-35 U/L 10-30 U/L 10-25 U/L 10-30 U/L 10-35 U/L 10-25 U/L 10-35 U/L 10-25 U/L 10-20 U/L 10-35 U/L Albumin 0-6
More informationEvaluation Report of the Pneumatic Tube Transport System (PEVCO) connecting Dialysis Hospital to. Mubarak Hospital. Dr.
5 Evaluation Report of the Transport System (PEVCO) connecting Dialysis Hospital to Mubarak Hospital Dr. Anwar AlAnjeri Senior Registrar Clinical Biochemistry Laboratory Mubarak Hospital Introduction:
More informationLaboratory Results Timeliness as a Quality Attribute and Strategy
Laboratory Results Timeliness as a Quality Attribute and Strategy Joan H. Howanitz, MD, and Peter J. Howanitz, MD Key Words: Turnaround time; Strategy; Quality improvement Abstract Although timeliness
More informationEvaluation of VACUETTE CAT Serum Fast Separator Blood Collection Tube for Routine Chemistry Analytes in Comparison to VACUTAINER RST Tube
Evaluation of VACUETTE CAT Serum Fast Separator Blood Collection Tube for Routine Chemistry Analytes in Comparison to VACUTAINER RST Tube Background: Greiner-Bio-One, Austria has been selling plastic evacuated
More informationDelta Check Calculation Guide
Delta Check Calculation Guide National Technology 2017, All Rights Reserved By Senior Scientific Researcher, Asmaa Taher Table of Contents Definition... 2 Purpose... 2 Delta Check Research Studies... 2
More informationLaboratory Automation and Intra- Laboratory Turnaround Time: Experience at the University Hospital Campus Bio-Medico of Rome
6458JLAXXX10.1177/2211068214566458Journal of Laboratory AutomationAngeletti et al. 015 Original Report Laboratory Automation and Intra- Laboratory Turnaround Time: Experience at the University Hospital
More informationComparison of VACUETTE Heparin Gel Tubes for Common Chemistry Analytes
Comparison of VACUETTE Heparin Gel Tubes for Common Chemistry Analytes Background: Greiner-Bio-One, Austria has been selling plastic evacuated tubes (VACUETTE ) for venous blood collection since 9. The
More informationCME/SAM. An Examination of the Usefulness of Repeat Testing Practices in a Large Hospital Clinical Chemistry Laboratory
Clinical Chemistry / Repeat Testing Practices in Clinical Chemistry An Examination of the Usefulness of Repeat Testing Practices in a Large Hospital Clinical Chemistry Laboratory Carl O. Deetz, MD, PhD,
More informationInspector's Accreditation Unit Activity Menu
01/12/20XX 15:58:57 Laboratory Accreditation Program Page 1 of 9 CHEMISTRY 1501 ALT, serum/plasma 1502 Albumin, serum/plasma 1504 Alkaline phosphatase, serum/plasma 1506 Amylase, serum/plasma 1508 Bilirubin,
More informationStability of VACUETTE Lithium Heparin Separator tubes with modified centrifugation conditions
Stability of VACUETTE Lithium Heparin Separator tubes with modified centrifugation conditions Background: Greiner-Bio-One, Austria has been selling plastic evacuated tubes (VACUETTE ) for venous blood
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
More informationHospital laboratories frequently receive requests to add
Evaluation of Add-on Testing in the Clinical Chemistry Laboratory of a Large Academic Medical Center Operational Considerations Stacy Foran Melanson, MD, PhD; Brian Hsieh; James G. Flood, PhD; Kent B.
More informationEvaluation of new MiniCollect Z Serum (Separator) Tubes
Evaluation of new MiniCollect Z Serum (Separator) Tubes Background: Greiner Bio-One has developed a newly designed MiniCollect tube offering an integrated collection scoop. The advantage of the new tube
More informationENROLLMENT CONFIRMATION
Step 1: Please review the Facility/Contact information. If any of the information is incorrect, please make the appropriate changes below: Facility/Contact Phone: (850)474-3660 Fax: (850)474-3659 6431
More informationEpic Labs Orderable As STAT PRIORITY As of 06/22/2016
ABG+HB(CORDARTERIAL) - BABY A ABG+HB(CORD ARTERIAL)- BABY B ABG+HB(CORD ARTERIAL)- BABY C ACETAMINOPHEN LEVEL ALANINE AMINOTRANSFERASE (ALT) ALBUMIN, FLUID ALBUMIN, PLEURAL FLUID ALBUMIN, SYNOVIAL FLUID
More informationSerodos and Serodos plus
Design Verification Serodos and Serodos plus Contents 1 Value Adjustment... 2 2 Target Determination... 2 3 Stability... 2 Real-Time Stability... 3 Stability after Reconstitution... 4 Stability after Reconstitution
More informationWSLH. Calibration Verification/ Linearity Products. roficiency. esting. Products provided in partnership with:
WSLH PT roficiency esting Calibration Verification/ Linearity Products Products provided in partnership with: www.wslhpt.org 800-462-5261 PTService@slh.wisc.edu General Chemistry Ammonia/Ethanol - 5 x
More informationGeneral Chemistry Scheme Guide
General Chemistry Scheme Guide Copyright WEQAS. All rights reserved. No part of this document may be reproduced or utilised in any form without permission from WEQAS Contents. Scheme details and repertoire.....
More informationCAP Laboratory Improvement Programs. Clinical Consequences of Specimen Rejection
CAP Laboratory Improvement Programs Clinical Consequences of Specimen Rejection A College of American Pathologists Q-Probes Analysis of 78 Clinical Laboratories Donald S. Karcher, MD; Christopher M. Lehman,
More informationNORMAL LABORATORY VALUES FOR CHILDREN
Pediatric Drug Lookup Normal Laboratory Values for NORMAL LABORATORY VALUES FOR CHILDREN CHEMISTRY Normal Values Albumin 0-1 y 2.0-4.0 g/dl 1 y to adult 3.5-5.5 g/dl Ammonia Newborns 90-150 mcg/dl 40-120
More informationSpecimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
More informationSpecimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
More informationEvidence Based Commutability: Bias 2 Study. Janice Gill Manager RCPAQAP Chemical Pathology Adelaide SA
Evidence Based Commutability: Bias 2 Study Janice Gill Manager RCPAQAP Chemical Pathology Adelaide SA Australian Bias Studies conducted by Gus Koerbin, ACT Pathology on behalf of AACB Harmonisation Committee
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Pathology Laboratory Contact: Gavyn Barrett BMI Blackheath Hospital Tel: +44 (0)20 7307 7373 40-42 Lee Terrace E-Mail: Gavyn.barrett@tdlpathology.com
More informationSetting of quality standards
Setting of quality standards Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney AACB ASM Adelaide October 2014 Setting of Quality Standards - 2013 The 2013 QC workshop revealed
More informationTotal Cost of Ownership (TCO): An evidence-based approach to compare laboratory equipment
Total Cost of Ownership (TCO): An evidence-based approach to compare laboratory equipment P.C.G. Gontard 1, L.I. Stankevich 1, B.G. Gorodetsky 1 SUMMARY Clinical laboratories across the globe operate in
More informationSupplementary materials
Supplementary materials Table S Adverse events identified by participants diary logs and blood hematologic and biochemical tests (n=2) group (n=) Placebo group (n=) P value for chi-squared test Asthma
More informationHamilton Regional Laboratory Medicine Program
Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, 2007. of Review: August 2009 of Review: December 2011;
More informationThe analytical phase
The analytical phase Result interpretation Test request Result Sampling Black box: the lab ANALYTICAL PHASE The CASE Uncle Pete, 67 years old Marked abdominal pain 8 pm, ED Acute abdomen? Assessment (+
More informationTables of Normal Values (As of February 2005)
Tables of Normal Values (As of February 2005) Note: Values and units of measurement listed in these Tables are derived from several resources. Substantial variation exists in the ranges quoted as normal
More informationAlaska Native Medical Center Anchorage, AK
ANMC Lab Test Requirements Key: Room Temp (20-25C), Refrigerated (2-8C), (-15 to -25C), Hr (Hours), D (Days), W (Weeks), Mo (Months), Yr (Years). Basic Processing Instructions: Centrifuge all blood specimens
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
More informationROTUNDA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE
This active test table informs the user of Biochemistry tests available in house. s referred to other sites are recorded in the Referred Table. Issue date: 4 TH April 2016 Contact Phone Number ext.1345/2522
More informationMonitoring the Impact of CPOE on Healthcare Delivery A Benefi ts Realisation Approach
Monitoring the Impact of CPOE on Healthcare Delivery A Benefi ts Realisation Approach Andrew Georgiou 1, Mary Lam 2, Johanna Westbrook 1 1 Health Informatics Research and Evaluation Unit, Faculty of Health
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Biochemistry Department Poole Hospital Longfleet Road Poole BH15 2JB Contact: Dr Fergus Jack Tel: +44 (0) 1202 442 497 E-Mail: Fergus.jack@poole.nhs.uk
More informationPrior to site activation the following events were lined up
Pardon Gomani CALENDAR OF EVENTS Prior to site activation the following events were lined up October 2008 Operational walk through in JHB 9 to 17 July study specific training Harare 27 August 09 site specific
More informationClinical Study Thrombin-Accelerated Quick Clotting Serum Tubes: An Evaluation with 22 Common Biochemical Analytes
Advances in Hematology Volume 13, Article ID 7979, 8 pages http://dx.doi.org/1.11/13/7979 Clinical Study Thrombin-Accelerated Quick Clotting Serum Tubes: An Evaluation with Common Biochemical Analytes
More informationHamilton Regional Laboratory Medicine Program
Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, 2007. of Review: August 2009 of Review: December 2011;
More informationUni-Asia Scientific Instrument Company Limited. Stanbio Laboratory Product List
0130-430 Magnesium LiquiColor Test 0140-050 Sodium Test 0150-250 Calcium (CPC) LiquiColor Test 0153-030 Calcium Standard (10 mg/dl) 0155-225 Calcium (Arsenazo) LiquiColor Test 0160-050 Potassium Test 0210-250
More informationVITROS MicroSlide Assay Summary
ACET Acetaminophen ALB Albumin EDTA 10 9 TDM PV Specialty 5.5 4 PV Isotonic saline or 10 200 μg/ml 66 1323 μmol/l (μmol/l = μg/ml x 6.616) 1.00 6.00 g/dl 10.0-60.0 g/l (g/l = g/dl x 10) Therapeutic: 670
More informationStability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation
Original Article Stability of common biochemical analytes in serum gel tubes subjected to various storage temperatures and times pre-centrifugation Melissa Tanner 1, Neil Kent 1, Brian Smith 2, Stephen
More informationInvestigating the recheck rules for urine analysis in children
Investigating the recheck rules for urine analysis in children Y.M. He*, S.W. Yao*, Y.J. Huang, B.S. Liang and H.Y. Liu Clinical Laboratory, Guangzhou Women and Children s Medical Center, Guangzhou Medical
More informationBASIC METABOLIC PANEL
Update 2/12/2018 BASIC METABOLIC PANEL CPT 80048 Stability: 3 days at 15-25 C; 7 days at 2-8 C; > 7 days at -70 C Colorimetric Assay, Rate reaction, ISE Components: BUN, Calcium, Chloride, CO2, Creatinine,
More informationPatient Safety: A Quality System Approach To POCT QC/QA
Patient Safety: A Quality System Approach To POCT QC/QA Ellis Jacobs, Ph.D., DABCC New York University School of Medicine Coler-Goldwater Specialty Hospital & Nursing Facility New York, New York Point-of-Care
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION LANCET KENYA LIMITED UPPERHILL NAIROBI LABORATORY Co. Reg. No.: C168507 Facility Accreditation Number: is a South African National Accreditation System accredited laboratory
More informationNEW RCPCH REFERENCE RANGES-
s vary between populations and age groups and it is important to always check the reference Haematology: Haemoglobin Male 130 175 g/l 0 6 days 145-220 g/l Female 115 165 g/l 7 days 140-186 g/l 8 days 3
More informationMultiple studies are available concerning the use of
SPECIAL ARTICLE Evaluation of the Biosite Ò Quantitative Whole Blood D-dimer Assay and Comparison With the biomérieux VIDAS Ò D-dimer Exclusion Test Validation and Utility For Use in the Central Laboratory
More informationPostanalytical phase
Postanalytical phase Test request POSTANALYTICAL Result interpretation PHASE Result Sampling Black box: the lab And the RESULT is created The technician approves the result; it is transferred to the lab
More informationWhat tests should be on the Alert List?
What tests should be on the Alert List? Dr Que Lam On behalf RCPA-AACB High Risk Results Working Party: Alan McNeil, Grahame Caldwell, Craig Campbell, Penelope Coates, Robert Flatman, Andrew Georgiou,
More informationCoping with Analytical Interferences
Coping with Analytical Interferences (Handling Icteric, Hemolytic and Lipaemic Samples) Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney Surabaya Indonesia 2016 Acknowledgements
More informationReference Intervals. Graham Jones / Gus Koerbin
Reference Intervals Graham Jones / Gus Koerbin Adult CRI - Harmonisation Harmonisation 1 2012: (13 tests + 1 calculation) Harmonisation 2 2013: Confirm 2012 recommendations. Discussed: albumin, globulin,
More informationManufacturer Report for Siemens Unassayed Chemistry Lot Exp 30 Jun 2018
Acetaminophen Enzymatic, colorimetric µg/ml.09 0..0.09 0..0 0. 0. 0. 0. 9.. 9.0 0.9.0..9.. Albumin Bromcresol Purple (BCP) g/dl.0 0.0..0 0.00.. 0.0.. 0.09..9 0.0..9 0.0..0 0.0..0 0.0. Alkaline Phosphatase
More information2008 CAP TODAY Q & A
2008 CAP TODAY Q & A Q. How often should we document hematology competencies to ensure consistency of morphologic observations for manual differentials and fluids? Should we do this every six months or
More informationCROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE
CROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE Croatian Centre for Quality Assessment in Laboratory Medicine Dear colleagues, Boskoviceva 18, 10000 Zagreb Croatia Tel/Phone & Fax: +385
More information1. Purpose 1.1. To define testing locations, schedule and order priority for each test performed in the core laboratory.
Department Of Pathology GEN.1017.03 Integrated Test Schedule Version# 5 Department Specimen Processing POLICY NO. 1938 PAGE NO. 1 OF 6 Printed copies are for reference only. Please refer to the electronic
More informationAvailable online at
Available online at www.annclinlabsci.org Annals of Clinical & Laboratory Science, vol. 45, no. 4, 2015 391 Influence of Vitamin C on Urine Dipstick Test Results Dae-Hyun Ko 1, Tae-Dong Jeong 1, Sollip
More informationOnline catalog
This catalog contains information about tests performed at Green Clinic Laboratory. For samples to be sent to Quest Diagnostics or any other reference lab please contact the Green Clinic Laboratory (318-251-6378)
More informationREFERENCE INTERVALS. Units Canine Feline Bovine Equine Porcine Ovine
REFERENCE INTERVALS Biochemistry Units Canine Feline Bovine Equine Porcine Ovine Sodium mmol/l 144-151 149-156 135-151 135-148 140-150 143-151 Potassium mmol/l 3.9-5.3 3.3-5.2 3.9-5.9 3.0-5.0 4.7-7.1 4.6-7.0
More informationEvaluation of VACUETTE Urine CCM tube for Clinical Chemistry
Evaluation of VACUETTE Urine CCM tube for Clinical Chemistry Background The VACUETTE Urine CCM tube is for the collection, transport and storage of urine samples for urine culture and urinalysis in the
More informationCAP Laboratory Improvement Programs. Utility of Repeat Testing of Critical Values. A Q-Probes Analysis of 86 Clinical Laboratories
CAP Laboratory Improvement Programs Utility of Repeat Testing of Critical Values A Q-Probes Analysis of 86 Clinical Laboratories Christopher M. Lehman, MD; Peter J. Howanitz, MD; Rhona Souers, MS; Donald
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Spire Portsmouth Hospital Bartons Road Havant PO9 5NP United Kingdom Contact: Natalie Peck E-Mail: natalie.peck@spirehealthcare.com Website:
More informationTRACEABILITY and UNCERTAINTY 7
Routine Method COBAS INTEGRA systems Acid phosphatase total 1-naphthyl phosphate Integra 00 plus Acid phosphatase total 1-naphthyl phosphate Acid phosphatase, non-prostatic Integra 00 plus Acid phosphatase,
More informationPresented by Marcelo Cardona, MT(ASCP) Johns Hopkins University
Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University Alert or critical values represent those assay results that require prompt, rapid clinical attention to avert significant study-participant
More informationBreakout Session C: Harmonisation of the Alert Table.
Breakout Session C: Harmonisation of the Alert Table. RCPA-AACB High Risk Results Working Party Andrew Georgiou Craig Campbell Grahame Caldwell Hans Schneider Penelope Coates Que Lam Rita Horvath Robert
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION LANCET LABORATORIES Registration No: 4120108883 Facility Accreditation Number: MED 006 is a SADCAS accredited Medical Laboratory provided that all SADCAS conditions are complied
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Spire Portsmouth Hospital Bartons Road Havant PO9 5NP United Kingdom Contact: Natalie Peck E-Mail: natalie.peck@spirehealthcare.com Website:
More informationStandatrol S-E. 2 niveles. Lyophilized serum for precision control in clinical chemistry
Lot: 1711232000 Level 1: 230680 Level 2: 230700 C Standatrol S-E 2 niveles Lyophilized serum for precision control in clinical chemistry USES Standatrol S-E 2 niveles is adaptable to different uses: -
More informationStandatrol S-E. 2 niveles. Lyophilized serum for precision control in clinical chemistry
Lot: 1702210520 Level 1: 201920 Level 2: 201930 C Standatrol S-E 2 niveles Lyophilized serum for precision control in clinical chemistry USES Standatrol S-E 2 niveles is adaptable to different uses: -
More informationStandatrol S-E. 2 niveles. Lyophilized serum for precision control in clinical chemistry
Lot: 1404137860 (Exp.: 2016/04) Level 1: 137860 (Exp.: 2016/04) Level 2: 137860 (Exp.: 2016/04) C Standatrol S-E 2 niveles Lyophilized serum for precision control in clinical chemistry USES Standatrol
More informationSydPath Reference Intervals for Clinical Trials (Contract Pathology Unit) Unauthorised Copy
HAEMATOLOGY APTT 1 150 M 25 35 sec APTT 1 150 F 25 35 sec Basophils Cord 2 weeks M 0.0 0.4 10^9/L Basophils Cord 2 weeks F 0.0 0.4 10^9/L Basophils 2 wks 3 mths M 0.0 0.2 10^9/L Basophils 2 wks 3 mths
More informationPatient Results Report
Sample Physician MD Sample Practice 2250 W. Campbell Park Dr. Chicago, IL 60612 Current Test Overview SAMPLE ID RESULTS TURNAROUND (IN DAYS) PATIENT COLLECTION LAB RECEIPT TEST COMPLETION S000000 2 08/03/2005
More informationICL Integrative Laboratory Services Test Menu Contact ICL Client Care x300
Alletess Food Sensitivity Fingerstick 96 Foods IgG with or without Wellness Program 184 Foods IgG with or without Wellness Program Alletess Food Allergy/Sensitivity Serum 96 Foods IgG with or without Wellness
More informationTRACEABILITY and UNCERTAINTY
ACP Acid phosphatase total 1-naphthyl phosphate NPP Acid phosphatase, non-prostatic 1-naphthyl phosphate (Inhib.:tartrate) ACP-P Acid phosphatase, prostatic 1-naphthyl phosphate (Inhib.:tartrate) ALB Albumin
More informationEvaluation of Cheongmeak DCS TM Reagents for Chemistry Analyzers
임상검사와정도관리 J Lab Med Qual Assur 2010 ; 32:197-204 ISSN 1225-097X Evaluation of Cheongmeak DCS TM Reagents for Chemistry Analyzers Kyeong Seob Shin, Taek Eun Jeong, and Bo Ra Son Department of Laboratory
More informationCAP Laboratory Improvement Programs. Comparative Analytical Costs of Central Laboratory Glucose and Bedside Glucose Testing
CAP atory Improvement Programs Comparative Analytical Costs of Central atory Glucose and Bedside Glucose Testing A College of American Pathologists Q-Probes Study Peter J. Howanitz, MD; Bruce A. Jones,
More informationTo be used for the ease of test requisitioning on select patients only; all components may be ordered separately
Panels Section To be used for the ease of test requisitioning on select patients only; all components may be ordered separately ANEMIA 1(I) PANEL (NMC & UMMC) ANEM1(I) S 8.0 ml Large Tests included are:
More informationQ Methodology to Measure Physician Satisfaction with Hospital Pathology Laboratory Services at a Midwest Academic Health Center Hospital
Q Methodology to Measure Physician Satisfaction with Hospital Pathology Laboratory Services at a Midwest Academic Health Center Hospital Laurie A. Gillard, MS, MT(ASCP) SBB, 1 Veronica N. Lewis, MS, MT(ASCP)
More information1. Calibra - H - Store at 2-8 ºC.
CALIBRA H Insert Ref.:80 Lot Expiration Calibrator Attention. It is suggested to verify carefully if the lot number printed in this insert corresponds to the lot on the bottle label. Intended use. is a
More information10 Essential Blood Tests PART 1
Presents 10 Essential Blood Tests PART 1 The Blood Chemistry Webinars With DR. DICKEN WEATHERBY Creator of the Blood Chemistry Software Essential Blood Test #1: Basic Chem Screen and CBC http://bloodchemsoftware.com
More informationGENERAL INFORMATION CLINICAL LABORATORY PHONE DIRECTORY
GENERAL INFORMATION CLINICAL LABORATORY PHONE DIRECTORY SECTION PHONE NUMBER Clinical Pathologist 431-5888 Laboratory Main Laboratory Administrative Director Janis Nall Accessioning/Client Services Section
More informationM.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017
M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017 If laboratory results are required on a STAT basis, the designated commercial medical laboratory
More informationAnalyte Specimen Demographic Reference Range Units
Acetone Negative titer Alanine aminotransferase (ALT/SGPT) 10-49 U/L Albumin 3.2-4.8 g/dl Alcohol < 10 Alpha-fetoprotein (AFP) < 1.3-8.1 ng/ml Alkaline phosphatase 0 7 days 7 30 days 1 3 3 6 6 12 1 3 3
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Hammersmith Medicines Research Limited Cumberland Avenue Park Royal London NW10 7EW Contact: Juan Naveda Tel: +44 (0) 20 8961 4130 Fax: +44
More informationRoche/Hitachi - PreciControl ClinChem Multi 2
ATRYP Antitrypsin alpha 1 ERM-DA470k/IFCC 9 136 1.36 1.84 0.0184 GPROT Acid glycoprotein alpha 1 CRM 470 2 90.1 0.901 0.890 0.00890 ACP Acid phosphatase total 1-naphthyl phosphate 0.720 43.1 0.00703 0.421
More informationQuestionnaire. Traceability in EQA. Traceability
Questionnaire in EQA QUESTIONNAIRE ON TRACEABILITY QUESTIONNAIRE ON TRACEABILITY GENERAL INFORMATION Name EQA organisation Country Specify the total number of measurands in the schemes of your EQA organisation
More informationTEST LIST SAMPLE REQUIREMENT. 1 ml serum None
ALBUMIN TEST NAME ALKALINE PHOSPHATASE ALLERGY PROFILE, FOOD 30 allergens ALLERGY PROFILE, INHALANT 30 Allergens ALT AMYLASE ANA ANTI- TG ANTI-GLIADIN IGG ANTI-GLIADIN IGA ANTI-HBS ANTI-HCV ANTI-TPO APOLIPOPROTEIN
More informationEffect of serum-clot contact time on clinical chemistry laboratory results
Clinical Chemistry 44:6 1325 1333 (1998) General Clinical Chemistry Effect of serum-clot contact time on clinical chemistry laboratory results Dongbo J. Zhang, 1 R.K. Elswick, 2 W. Greg Miller, 1* and
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Laboratory locations: 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK - Cheltenham Hospital Hatherley Lane Cheltenham GL51 6SY Contact: Chris Watson Tel: +44 (0) 1242 246516 E-Mail: chris.watson@nuffieldhealth.com
More informationPhysician Office Laboratory Tests
Important Change Effective March 1, 2018 Physician Office Laboratory Tests Molina Healthcare of Michigan has updated its list of payable laboratory tests that may be performed in a physician s office.
More informationControlled storage conditions prolong stability of biochemical components in whole blood
Clin Chem Lab Med 2005;43(2):210 215 2005 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2005.036 Controlled storage conditions prolong stability of biochemical components in whole blood Marta
More informationBiochemistry Department Laboratory Handbook
Biochemistry Department Laboratory Handbook Version : 3.3 Page 1 of 12 Table of contents Biochemistry Department... 1 Laboratory Handbook... 1 Introduction... 3 The Biochemistry Department... 3 High risk
More informationMore to Life. Where research becomes the basis of discovering newer ways of alleviating human suffering and empowering an individual with good health.
More to Life Where research becomes the basis of discovering newer ways of alleviating human suffering and empowering an individual with good health. Meril Diagnostics Emerging from a lineage of successful
More informationControls & Calibrators Clinical Chemistry
Controls & Calibrators Clinical Chemistry Clinical Chemistry Controls & Lipids Clinical Chemistry and lipid quality controls have been manufactured from true human serum to ensure they perform the same
More informationOUTLINE OF QUALITY INDICATOR IN CLINICAL LABORATORY
OUTLINE OF QUALITY INDICATOR IN CLINICAL LABORATORY *Jayesh Warade Department of Laboratory Medicine, Meenakshi Mission Hospital and Research Centre, Madurai *Author for Correspondence ABSTRACT While quality
More informationLaboratory Accreditation Programmes
Client No. 1609 LABNET Invermay Limited PO Box 371, Mosgiel, 9053 Puddle Alley, RD 2, Mosgiel, 9092 Telephone 03 489-4600 www.gribblesvets.co.nz Fax 03 489-8576 Authorised Representative Ms Denise Carian-Smith
More information